Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

Manufactured by Eli Lilly and Company, Zepbound ... Invest Before Funding Closes According to a recent news release, Eli Lilly's clinical trials for Zepbound showed promising results. After ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 465.16% and ...

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

For example, LLY’s Zepbound sales are projected to double from the prior year to $11.3B after the U.S. FDA approved ... franchise’s long-term prospects before the drug's U.S. market ...

You'll need insurance approval before filling your Ozempic prescription ... If you have insurance, but the plan won't cover Zepbound, you'll pay $597 per month after the drug maker's discount. The ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.